PATIENT DRIVEN SCIENTIFIC DEVELOPMENT
Product Uniqueness
STABLE PSILOCIN FORMULATION
Disease targeted formulation
based on scientific research
Precise formulation, and dosing strategy
with pharmaceutical accuracy
Clear path to market,
which will enable products that can be covered by health insurance
COMPANY POLICIES
Available Upon Request
Psychedelic Renaissance
TEAM
MIRIAM OREILLY
CEO / FOUNDER
Mechanical Engineer with Masters in Industrial Engineering Management. 20 years’ experience in establishing and leading operations and complex projects. Experience in bringing EU GMP medical Cannabis to the UK Market. Founder of Haim Pharma Group.
ROBIN DE BRJUIN
CTO
Robin is an expert in drug delivery systems and previously co- founded multiple successful companies. With a cum laude master degree in Process Engineering and a Master of Business Innovation he brings a lot of technical and analytical knowledge to the team.